Spirecut, a Muttenz-based medtech start-up, is revolutionizing hand surgery with a groundbreaking ultrasound-guided technique spearheaded by CEO Frédéric Schuind. Moving away from traditional incision-based methods, Spirecut’s innovation requires a minor puncture to treat common hand disorders such as trigger finger and carpal tunnel syndrome.”
Continue reading
On Friday, June 23rd, Spirecut hosted a training session at Sitem-insel AG, located in Bern, Switzerland. The session primarily focused on the ultrasound-guided percutaneous surgical treatments of two prevalent hand conditions: trigger fingers and carpal tunnel syndrome. Participants included future Key Opinion Leaders (KOLs).
Continue reading
Prof Frédéric Schuind, Spirecut’s founder and CEO, recently participated in the X-Health.show podcast. The discussion centered around the latest breakthroughs in hand surgery, with a particular emphasis on trigger finger and carpal tunnel syndrome treatments.
Continue reading
Spirecut’s European patent has been officially approved. This represents a significant milestone for our company as it reinforces our intellectual property portfolio. This development will enable us to expand our solutions across Europe, fostering innovation and enhancing healthcare in the region.
Continue reading
The study involved 30 adult participants, equally divided between the two conditions under investigation. One of the critical aspects of this research was the assessment of safety, gauged by the number of severe peri- and post-operative adverse events.
Continue reading
We recently attended Startup Days (SUD), Switzerland’s premier startup conference, providing insights into our innovative solutions and opportunities for meaningful discussions and partnerships.
Continue reading